-
1
-
-
0029068463
-
Managing research centers as a portfolio of strategic resources
-
Getz K.A., Fisher S.F., Brookman S. Managing research centers as a portfolio of strategic resources. Drug Inf. J. 29:1995;551-562
-
(1995)
Drug Inf. J.
, vol.29
, pp. 551-562
-
-
Getz, K.A.1
Fisher, S.F.2
Brookman, S.3
-
2
-
-
0029791311
-
Optimizing clinical site selection
-
McFarland L.V. Optimizing clinical site selection. Drug Inf. J. 30:1996;793-798
-
(1996)
Drug Inf. J.
, vol.30
, pp. 793-798
-
-
McFarland, L.V.1
-
3
-
-
0042196734
-
Why investigators take part in clinical trials
-
Glass H.E., Kane R.A. Why investigators take part in clinical trials. Appl. Clin. Trials. 2000 (June);46-54
-
(2000)
Appl. Clin. Trials
, pp. 46-54
-
-
Glass, H.E.1
Kane, R.A.2
-
4
-
-
3543003306
-
Best practices for site start-up and subject enrollment
-
Sietsema W.K. Best practices for site start-up and subject enrollment. Appl. Clin. Trials. 1999 (September);58-66
-
(1999)
Appl. Clin. Trials
, pp. 58-66
-
-
Sietsema, W.K.1
-
5
-
-
0037328623
-
Emergency medicine leadership in industry-sponsored clinical trials
-
Newgard C.D., Kim S., Camargo C.A. Emergency medicine leadership in industry-sponsored clinical trials. Acad. Emerg. Med. 10:2003;169-174
-
(2003)
Acad. Emerg. Med.
, vol.10
, pp. 169-174
-
-
Newgard, C.D.1
Kim, S.2
Camargo, C.A.3
-
6
-
-
0037116805
-
What to do about poor clinical performance in clinical trials
-
Mason S., Nicholl J., Lilford R. What to do about poor clinical performance in clinical trials. BMJ. 324:2002;419-421
-
(2002)
BMJ
, vol.324
, pp. 419-421
-
-
Mason, S.1
Nicholl, J.2
Lilford, R.3
-
7
-
-
0037608591
-
Selecting sites and investigators. An approach for Central and Eastern Europe
-
Demeter J. Selecting sites and investigators. An approach for Central and Eastern Europe. Appl. Clin. Trials. 2002 (March);56-65
-
(2002)
Appl. Clin. Trials
, pp. 56-65
-
-
Demeter, J.1
-
8
-
-
0031739048
-
Site selection for clinical trials
-
[Suppl.]
-
De Silva J. Site selection for clinical trials. Drug Inf. J. 32:1998;1257S-1258S. [Suppl.]
-
(1998)
Drug Inf. J.
, vol.32
-
-
De Silva, J.1
-
9
-
-
3543042275
-
Consider geography when choosing investigator sites
-
Schaub W. Consider geography when choosing investigator sites. Appl. Clin. Trials. 2002 (March);68-72
-
(2002)
Appl. Clin. Trials
, pp. 68-72
-
-
Schaub, W.1
-
10
-
-
0032694009
-
Incorporating affiliates and contract research organizations into global clinical trials
-
Harrill S.M., Boswick J.M., Crouch T.C., Cahillane G., Watson H., Meloy S.M. Incorporating affiliates and contract research organizations into global clinical trials. Drug Inf. J. 33:1999;1033-1052
-
(1999)
Drug Inf. J.
, vol.33
, pp. 1033-1052
-
-
Harrill, S.M.1
Boswick, J.M.2
Crouch, T.C.3
Cahillane, G.4
Watson, H.5
Meloy, S.M.6
-
11
-
-
0035217053
-
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): Clinical center recruitment experience
-
Wright J.T., et al. for the ALLHAT Research Group The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): clinical center recruitment experience. Control. Clin. Trials. 22:2001;659-673
-
(2001)
Control. Clin. Trials
, vol.22
, pp. 659-673
-
-
Wright, J.T.1
-
12
-
-
0344255785
-
Web-based decision support for clinical trial eligibility determination in an international clinical trials network
-
Breitfeld P.P, Ullrich F., Anderson J., Crist W.M. Web-based decision support for clinical trial eligibility determination in an international clinical trials network. Control. Clin. Trials. 24:2003;702-710
-
(2003)
Control. Clin. Trials
, vol.24
, pp. 702-710
-
-
Breitfeld, P.P.1
Ullrich, F.2
Anderson, J.3
Crist, W.M.4
-
13
-
-
0035666481
-
Carotid Revascularization with Endarterectomy or Stenting Systems (CARESS): Investigator selection
-
CARESS Steering Committee Carotid Revascularization with Endarterectomy or Stenting Systems (CARESS): investigator selection. J. Endovasc. Ther. 8:2001;547-549
-
(2001)
J. Endovasc. Ther.
, vol.8
, pp. 547-549
-
-
Steering Committee, C.1
-
14
-
-
1842488712
-
New drug discovery and development in India
-
[Supplement]
-
Maggon K. New drug discovery and development in India. Drug News Perspect. 16:2003;1-19. [Supplement]
-
(2003)
Drug News Perspect.
, vol.16
, pp. 1-19
-
-
Maggon, K.1
-
15
-
-
1842454199
-
A passage to India
-
Maggon K. A passage to India. Good Clin. Trials J. 10:2003;29-32
-
(2003)
Good Clin. Trials J.
, vol.10
, pp. 29-32
-
-
Maggon, K.1
-
16
-
-
3543044773
-
Role of CROs in new drug development
-
March 25
-
Maggon K. Role of CROs in new drug development. Express Pharma Pulse. 2004 (March 25);. [http://www.expresspharmapulse.com/20040325/editorial02.shtml]
-
(2004)
Express Pharma Pulse
-
-
Maggon, K.1
-
17
-
-
3542993069
-
Clinical studies with new drugs: My Indian experiences
-
March 4
-
Maggon K. Clinical studies with new drugs: my Indian experiences. Express Pharma Pulse. 2004 (March 4);. [http://www.expresspharmapulse.com/20040304/ editorial02.shtml]
-
(2004)
Express Pharma Pulse
-
-
Maggon, K.1
-
18
-
-
0037417529
-
Efficacy and cost-effectiveness of drug and psychological treatments for common mental disorders in general health care in Goa, India: A randomised, controlled trial
-
Patel V., Chisholm D.I., Rabe-Hesketh S., Dias-Saxena F., Andrew G., Mann A. Efficacy and cost-effectiveness of drug and psychological treatments for common mental disorders in general health care in Goa, India: a randomised, controlled trial. Lancet. 361:2003;33-39
-
(2003)
Lancet
, vol.361
, pp. 33-39
-
-
Patel, V.1
Chisholm, D.I.2
Rabe-Hesketh, S.3
Dias-Saxena, F.4
Andrew, G.5
Mann, A.6
-
19
-
-
0345130115
-
Clinical trial potential of academic centers in India
-
Bhandari M., Rao T.H.S.G., Kumar A. Clinical trial potential of academic centers in India. Transplant. Proc. 31:1999;1104-1105
-
(1999)
Transplant. Proc.
, vol.31
, pp. 1104-1105
-
-
Bhandari, M.1
Rao, T.H.S.G.2
Kumar, A.3
-
21
-
-
1842540789
-
Global clinical trials in India - Challenges and opportunities
-
Bakhle D. Global clinical trials in India - challenges and opportunities. Business Briefing Pharmatech, Mumbai. 2003;109-110
-
(2003)
Business Briefing Pharmatech, Mumbai
, pp. 109-110
-
-
Bakhle, D.1
-
22
-
-
1842488717
-
Be clinical about trials
-
Mumbai, and 28 August
-
Sai, J.S., Be clinical about trials. Express Pharma Pulse Pharma Research, Mumbai, and 28 August 2003 [http://www.expresspharmapulse.com/ research.pdf].
-
(2003)
Express Pharma Pulse Pharma Research
-
-
Sai, J.S.1
-
24
-
-
3543014197
-
Proposed changes in schedule Y - A step forward
-
13 November
-
Bhatt A.D. Proposed changes in schedule Y - a step forward. Express Pharma Pulse. 2003 (13 November);. [http://www.expresspharmapulse.com/20031113/ pharmaexpo0303.shtml]
-
(2003)
Express Pharma Pulse
-
-
Bhatt, A.D.1
-
25
-
-
3543000884
-
2010. Indian clinical research odyssey
-
26 February
-
Bhatt A., Sahoo U. 2010. Indian clinical research odyssey. Chron. Pharmabiz. 2004 (26 February);22-23
-
(2004)
Chron. Pharmabiz
, pp. 22-23
-
-
Bhatt, A.1
Sahoo, U.2
-
26
-
-
3543031446
-
CROs: Beneficial to Indian patients
-
January 2
-
Varawalla N.Y. CROs: beneficial to Indian patients. Express Pharma Pulse. 2004 (January 2);. [http://www.expresspharmapulse.com/20040101/editorial02. shtml]
-
(2004)
Express Pharma Pulse
-
-
Varawalla, N.Y.1
-
27
-
-
0003962632
-
-
29 January
-
Clinical trials in India Patient Capital Economist. 2000 (29 January);83-84
-
(2000)
Economist
, pp. 83-84
-
-
-
29
-
-
3542991887
-
Unending queue of unethical drug trials
-
February 29, 2004 and Express Pharma Pulse March 11
-
Gulhati, C.M., Unending queue of unethical drug trials. Monthly Index of Medical Specialities MIMS. February 29, 2004 and Express Pharma Pulse March 11, 2004 [http://www.expresspharmapulse.com/20040311/editorial02.shtml].
-
(2004)
Monthly Index of Medical Specialities MIMS
-
-
Gulhati, C.M.1
-
30
-
-
0035944915
-
Johns Hopkins admits scientist used Indian patients as guinea pigs
-
24 November
-
Mudur G. Johns Hopkins admits scientist used Indian patients as guinea pigs. Br. Med. J. 323:2001 (24 November);1204
-
(2001)
Br. Med. J.
, vol.323
, pp. 1204
-
-
Mudur, G.1
-
31
-
-
3543017145
-
India admits to unapproved drug formulations in market
-
14 June
-
Mudur G. India admits to unapproved drug formulations in market. Br. Med. J. 326:2003 (14 June);1286
-
(2003)
Br. Med. J.
, vol.326
, pp. 1286
-
-
Mudur, G.1
-
32
-
-
3543029009
-
Monetary compensation attracts poor to drug trials
-
Ahmedabad. (13 September). .
-
Monetary compensation attracts poor to drug trials. The Times of India. Ahmedabad. 2002 (13 September). http://timesofindia.indiatimes.com/cms.dll/ articleshow?msid=22092939.
-
(2002)
The Times of India
-
-
-
33
-
-
10744228833
-
Doctors in India prescribe unapproved fertility drug
-
Mudur G. Doctors in India prescribe unapproved fertility drug. Br. Med. J. 327:2003;768
-
(2003)
Br. Med. J.
, vol.327
, pp. 768
-
-
Mudur, G.1
-
34
-
-
3543000297
-
Unethical promotion in India
-
April 8
-
Maggon K. Unethical promotion in India. Express Pharma Pulse. 2004 (April 8);. [http://www.expresspharmapulse.com/20040408/editorial02.shtml]
-
(2004)
Express Pharma Pulse
-
-
Maggon, K.1
-
35
-
-
3042621150
-
Comparative evaluation of the efficacy, safety, and tolerability of rosuvastatin 10 mg with atorvastatin 10 mg in adult patients with hypercholesterolaemia: The first Indian study
-
[
-
Jayaram S., Jain M.M., Naikawadi A.A., Gawde A., Desai A. Comparative evaluation of the efficacy, safety, and tolerability of rosuvastatin 10 mg with atorvastatin 10 mg in adult patients with hypercholesterolaemia: the first Indian study. JIMA. 101:2004;48-52. [http://www.jimaonline.org/january2004/ jan2004_Research%20Analysis%20Report.htm]
-
(2004)
JIMA
, vol.101
, pp. 48-52
-
-
Jayaram, S.1
Jain, M.M.2
Naikawadi, A.A.3
Gawde, A.4
Desai, A.5
-
36
-
-
1842454151
-
Marketing of medicines in India
-
Gulhati C.M. Marketing of medicines in India. BMJ. 328:2004;778-779
-
(2004)
BMJ
, vol.328
, pp. 778-779
-
-
Gulhati, C.M.1
|